{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:36:41Z","timestamp":1762101401865},"reference-count":42,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.055","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T18:01:22Z","timestamp":1362592882000},"page":"2119-2125","source":"Crossref","is-referenced-by-count":8,"title":["Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions"],"prefix":"10.1016","volume":"31","author":[{"given":"Konstantin","family":"Virnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Berkower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2013.02.055_bib0005","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1128\/JVI.65.11.5983-5990.1991","article-title":"A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120","volume":"65","author":"Berkower","year":"1991","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.02.055_bib0010","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1128\/JVI.65.11.6188-6193.1991","article-title":"Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody","volume":"65","author":"Thali","year":"1991","journal-title":"J Virol"},{"issue":"6049","key":"10.1016\/j.vaccine.2013.02.055_bib0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"6049","key":"10.1016\/j.vaccine.2013.02.055_bib0020","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"issue":"6353","key":"10.1016\/j.vaccine.2013.02.055_bib0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition","volume":"354","author":"Phillips","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.02.055_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.med.042508.093728","article-title":"HIV-1 vaccine development after STEP","volume":"61","author":"Barouch","year":"2010","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.055_bib0035","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.02.055_bib0040","doi-asserted-by":"crossref","unstructured":"Montero M, van Houten NE, Wang X, Scott JK. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 2008 Mar;72(1):54\u201384, table of contents.","DOI":"10.1128\/MMBR.00020-07"},{"issue":"6869","key":"10.1016\/j.vaccine.2013.02.055_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"6686","key":"10.1016\/j.vaccine.2013.02.055_bib0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"issue":"Dec (6916)","key":"10.1016\/j.vaccine.2013.02.055_bib0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"Kwong","year":"2002","journal-title":"Nature"},{"issue":"Aug (2)","key":"10.1016\/j.vaccine.2013.02.055_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.virol.2008.03.040","article-title":"Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding","volume":"377","author":"Berkower","year":"2008","journal-title":"Virology"},{"issue":"Jun (10)","key":"10.1016\/j.vaccine.2013.02.055_bib0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0b013e32835474d2","article-title":"The design and evaluation of HIV-1 vaccines","volume":"26","author":"Saunders","year":"2012","journal-title":"AIDS"},{"issue":"Jul","key":"10.1016\/j.vaccine.2013.02.055_bib0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM196007282630408","article-title":"Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine","volume":"263","author":"Katz","year":"1960","journal-title":"The New England journal of medicine"},{"issue":"Aug (6)","key":"10.1016\/j.vaccine.2013.02.055_bib0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM196808082790607","article-title":"Live, attenuated rubella-virus vaccine","volume":"279","author":"Hilleman","year":"1968","journal-title":"The New England journal of medicine"},{"issue":"May (RR-8)","key":"10.1016\/j.vaccine.2013.02.055_bib0080","first-page":"1","article-title":"Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"Feb (2)","key":"10.1016\/j.vaccine.2013.02.055_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/5557","article-title":"Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques","volume":"5","author":"Baba","year":"1999","journal-title":"Nat Med"},{"issue":"Sep (5)","key":"10.1016\/j.vaccine.2013.02.055_bib0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"Mar (2)","key":"10.1016\/j.vaccine.2013.02.055_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/viro.2001.1345","article-title":"Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model","volume":"294","author":"Earl","year":"2002","journal-title":"Virology"},{"issue":"Mar (5)","key":"10.1016\/j.vaccine.2013.02.055_bib0100","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JVI.78.5.2212-2221.2004","article-title":"Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting","volume":"78","author":"Patterson","year":"2004","journal-title":"J Virol"},{"issue":"Oct (42)","key":"10.1016\/j.vaccine.2013.02.055_bib0105","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2005.05.034","article-title":"Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660","volume":"23","author":"Johnston","year":"2005","journal-title":"Vaccine"},{"issue":"Apr","key":"10.1016\/j.vaccine.2013.02.055_bib0110","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/JVI.02453-06","volume":"7","author":"Demberg","year":"2007","journal-title":"J Virol"},{"issue":"Dec (6)","key":"10.1016\/j.vaccine.2013.02.055_bib0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2013.02.055_bib0120","series-title":"Vaccines","first-page":"707","article-title":"Rubella Vaccine","author":"Plotkin","year":"2004"},{"issue":"Aug (37)","key":"10.1016\/j.vaccine.2013.02.055_bib0125","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1016\/j.vaccine.2012.06.074","article-title":"Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers","volume":"30","author":"Virnik","year":"2012","journal-title":"Vaccine"},{"issue":"Sep (17)","key":"10.1016\/j.vaccine.2013.02.055_bib0130","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1128\/JVI.77.17.9502-9510.2003","article-title":"Complementation of a deletion in the rubella virus p150 nonstructural protein by the viral capsid protein","volume":"77","author":"Tzeng","year":"2003","journal-title":"J Virol"},{"issue":"Feb (5)","key":"10.1016\/j.vaccine.2013.02.055_bib0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.vaccine.2009.11.037","article-title":"Stable expression of a foreign protein by a replication-competent rubella viral vector","volume":"28","author":"Spadaccini","year":"2010","journal-title":"Vaccine"},{"issue":"Sep (9)","key":"10.1016\/j.vaccine.2013.02.055_bib0140","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.73.9.7805-7811.1999","article-title":"Intracellular distribution of rubella virus nonstructural protein P150","volume":"73","author":"Kujala","year":"1999","journal-title":"J Virol"},{"issue":"Dec (12)","key":"10.1016\/j.vaccine.2013.02.055_bib0145","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Dec (18)","key":"10.1016\/j.vaccine.2013.02.055_bib0150","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Apr (8)","key":"10.1016\/j.vaccine.2013.02.055_bib0155","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.02588-06","article-title":"An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10","volume":"81","author":"Nelson","year":"2007","journal-title":"J Virol"},{"issue":"Jan (2)","key":"10.1016\/j.vaccine.2013.02.055_bib0160","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/JVI.75.2.738-749.2001","article-title":"CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing","volume":"75","author":"Allen","year":"2001","journal-title":"J Virol"},{"issue":"Oct (8)","key":"10.1016\/j.vaccine.2013.02.055_bib0165","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.173.8.5064","article-title":"Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition","volume":"173","author":"Loffredo","year":"2004","journal-title":"J Immunol"},{"issue":"Jun (24)","key":"10.1016\/j.vaccine.2013.02.055_bib0170","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1073\/pnas.0813106106","article-title":"Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection","volume":"106","author":"Sacha","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Oct (4)","key":"10.1016\/j.vaccine.2013.02.055_bib0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.95.4.743","article-title":"Experimental rubella virus infection in the rhesus monkey","volume":"95","author":"Parkman","year":"1965","journal-title":"J Immunol"},{"issue":"Aug (2)","key":"10.1016\/j.vaccine.2013.02.055_bib0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0042-6822(03)00384-2","article-title":"Structural maturation of rubella virus in the Golgi complex","volume":"312","author":"Risco","year":"2003","journal-title":"Virology"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2013.02.055_bib0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0912914107","article-title":"Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance","volume":"107","author":"Verkoczy","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Nov (11)","key":"10.1016\/j.vaccine.2013.02.055_bib0190","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1128\/JVI.70.11.7910-7920.1996","article-title":"Interactions between PE2, E1, and 6K required for assembly of alphaviruses studied with chimeric viruses","volume":"70","author":"Yao","year":"1996","journal-title":"J Virol"},{"issue":"Dec (24)","key":"10.1016\/j.vaccine.2013.02.055_bib0195","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2013.02.055_bib0200","series-title":"Fundamental immunology","first-page":"631","article-title":"Immunogenicity and Antigen Structure","author":"Berzofsky","year":"2008"},{"issue":"Dec (5090)","key":"10.1016\/j.vaccine.2013.02.055_bib0205","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.1470917","article-title":"Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene","volume":"258","author":"Daniel","year":"1992","journal-title":"Science"},{"issue":"May (7348)","key":"10.1016\/j.vaccine.2013.02.055_bib0210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:42:04Z","timestamp":1688082124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13002442"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}